Comprehensive search ChatGPT Online Scientific research tools
Sign in Sign Up

Science hub Mutual Aid community


[Elsevier] Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Ahmed_1 Post time 4 day(s) ago | Show all posts |Read mode
Reward10points



july 2022

Authors : Kristian Reich 1, Jacob P Thyssen 2, Andrew Blauvelt 3, Kilian Eyerich 4, Weily Soong 5, Zakiya P Rice 6, H Chih-Ho Hong 7, Norito Katoh 8, Fernando Valenzuela 9, Marco DiBonaventura 10, Tamara A Bratt 11, Fan Zhang 11, Claire Clibborn 12, Ricardo Rojo 11, Hernan Valdez 10, Urs Kerkmann 13

DOi : https://doi.org/10.1016/S0140-6736(22)01199-0

PDF link : Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial - PubMed (nih.gov)

lancet

Best Answer

Nixxiflo Junior Member
4 day(s) ago
Please adopt

View Full Content

You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply1 Show all posts
Nixxiflo Post time 4 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

Ahmed_1 Lv.2
Junior Member

  • post

  • reply

  • points

    60

Same Category

Latest Reply

Announcement

Enthusiastic users today

Return to the list